We have chosen to pursue translational research projects in the challenging area of variation (heterogeneity) of patient outcomes as our initial focus. New molecular insights into the development of cancer have revealed increasing layers of heterogeneity that reflects not only the diversity of tumour cell behaviour, the impact of the micro-environment surrounding cancer cells, and also the macro-environment of host biology in the context of cancer control. We shall study not only cancer biology, but also the interaction of cancer cells with the host, society and the sustainability of the health care system and illness management.
NODE LEADER
DR. MARCO MARRA Vancouver, BC - The Terry Fox Research Institute (TFRI) is pleased to announce the appointment of Dr. Marco Marra to the executive team of TFRI. Dr. Marra is director of Canada's Michael Smith Genome Sciences Centre (GSC) at the BC Cancer Agency and a former holder of a Terry Fox Young Investigators Award (2004).
He is a Distinguished Scientist with the BC Cancer Agency, a Professor of Medical Genetics at the University of British Columbia, and an adjunct Professor of Molecular biology and Biochemistry at Simon Fraser University. A full biographical sketch is attached. The BC Cancer Agency and UBC are among TFRI's 41 national partners.
Are you looking for information about a Terry Fox-funded research project? You can access information about our projects through an online database. The information is available from the Canadian Institutes for Health Research's searchable database and appear on the national Canadian Research Information System (CRIS) database. The database is searchable by subject, investigator, funding, location or program.
